| Serge Weinberg |
Serge Weinberg is a French businessperson who founded Institut du Cerveau et de la Moelle Épinière and Weinberg Capital Partners SAS and who has been at the head of 19 different companies. Currently, he occupies the position of Chairman at Maremma SASU, Chairman of Financière Piasa SAS, Chairman for Piasa Holding SAS, Chairman at Sanofi, President at Weinberg Capital Partners SAS and Manager at Maremma. He is also on the board of Piasa SA (former Chairman) and AFEPT and Manager of Alret and Member of Council on Foreign Relations, Inc.
In his past career Mr. Weinberg was Chairman-Supervisory Board of Tess SAS, Chairman & Chief Executive Officer at Rexel SA, Chairman at Accor SA, Chairman at CORUM Vermögensverwaltung AG, Chairman-Supervisory Board of Financière Tess SAS, Chairman-Supervisory Board of Financière Climater SAS, Director at VL Holding (France), Chief Executive Officer & Director at Pallas Finance, Chairman-Management Board at Kering SA, President-CFAO at Pinault SARL, Manager for Adoval, Chairman at Montres CORUM Sà rl, Chairman & Chief Executive Officer at Havas Tourisme, President for Compagnie Française de L'Afrique Occidentale SA and Deputy General Manager-Finance at France 3 SA.
Serge Weinberg received a graduate degree from Institut d'Études Politiques d'Aix-en-Provence and an undergraduate degree from Ecole Nationale d'Administration. |
| Bernard Charlès |
Bernard Charlès is a French businessperson who has been at the helm of 15 different companies and currently occupies the position of Vice Chairman & Chief Executive Officer of Dassault Systèmes SA and Chairman at Dassault Systemes Geovia, Inc., Chairman for Centric Software, Inc., Chairman & Chief Executive Officer for Exa Corp., Chairman of IQMS, Chairman of Dassault Systèmes Corp., Chairman of Dassault Systemes Simulia Corp. and Chief Executive Officer & Vice Chairman at Exalead SA (which are all subsidiaries of Dassault Systèmes SA) and Chairman at Dassault Systemes Solidworks Corp. Bernard Charlès is also on the board of Sanofi and Member of National Academy of Engineering.
In the past he was Chairman for Dassault Systèmes Canada Software, Inc., Chairman-Supervisory Board for Dassault Systemes 3DExcite GmbH, Chairman at Dassault Systemes Biovia Corp., Chairman at Dassault Systemes Enovia Corp., Chairman at Delmia Corp., President for Dassault Systèmes Canada, Inc. and Member of Académie des Technologies.
He received an undergraduate degree from École normale supérieure de Cachan. |
| John C. Reed |
John C. Reed founded Apoptos, Inc. and Idun Pharmaceuticals, Inc. Currently, Dr. Reed holds the position of Head-Global Research & Development at Sanofi. He is also on the board of BIOCOM.
In the past he was Head-Roche Pharma Research & Early Development at Roche Holding AG, President, Chief Executive Officer & Professor at Sanford Burnham Prebys Medical Discovery Institute, Associate Member at the University of California San Diego, Assistant Director at the University of Pennsylvania and Associate Member at Whitaker Institute of Biomedical Engineering.
John C. Reed received an undergraduate degree from the University of Virginia and a doctorate from Perelman School of Medicine. |
| Patrick Kron |
Patrick Kron is a French businessperson who founded Pkc&I SAS and who has been at the head of 12 different companies. Presently, he is Chairman at this company and Chairman & Chief Executive Officer at Imerys SA. Mr. Kron is also on the board of 7 other companies.
In the past he held the position of Chairman & Chief Executive Officer at Alstom SA Chairman & Chief Executive Officer at Alstom Transport SA, Chairman at ALSTOM Resources Management SAS, Chief Executive Officer & Director at Alstom Asia Pacific Sdn. Bhd. and Managing Director & Director at Alstom Asia Pte Ltd. (which are all subsidiaries of Alstom SA), Chairman for Mersen SA and Chairman & Chief Executive Officer at Carbone Lorraine Applications Electriques (a subsidiary of Mersen SA), Chief Executive Officer of Vivendi SA, Chairman & Chief Executive Officer at Pechiney Electrométallurgie SA, Chief Executive Officer at Imerys SA, Chief Operating Officer of American National Can Corp and Manager-Food & Health Care Packaging Sector at Pechiney SA.
Patrick Kron received an undergraduate degree from Ecole Polytechnique and an undergraduate degree from École Nationale Supérieure des Mines de Paris. |
| Jérôme Contamine |
Currently, Jérôme Contamine is President of Sanofi 1 and Chief Financial Officer & Executive VP-Finance at Sanofi, Chairman at Secipe SA, Chief Executive Officer at Sanofi-Aventis Participations SAS, Chief Executive Officer of Sanofi-Aventis Europe SAS, Chief Financial Officer & Executive Vice President for Sanofi-Aventis U.S. LLC and Manager of Sanofi 4 (which are all subsidiaries of Sanofi). Jérôme Contamine is also on the board of Société Générale SA and Sanofi Pasteur Holding SA and Manager at Sanofi 4.
In the past Mr. Contamine was Vice President-Finance at Veolia Environnement SA, Chief Financial Officer for Rhodia SA and Vice President for Total E&P Norge AS.
He received an undergraduate degree from Ecole Polytechnique, an undergraduate degree from Ecole Nationale de la Statistique & de l'Administration and an undergraduate degree from Ecole Nationale d'Administration. |
| Alan J. Main |
Alan J. Main is Executive Vice President-CMC & Supply Operations at Lexicon Pharmaceuticals, Inc.
He previously held the position of President & Chief Executive Officer of Coelacanth Corp and Senior Vice President-US Research at Novartis Pharmaceuticals Corp.
Alan J. Main received an undergraduate degree from the University of Aberdeen and a doctorate from The University of Liverpool. |
| George Grofik |
Currently, George Grofik occupies the position of Head-Investor Relations for Sanofi.
In his past career he was Research Analyst at Citigroup Global Markets, Inc. (Broker). |
| Muzammil M. Mansuri |
Currently, Muzammil M. Mansuri is Executive Chairman at Adaptive Therapeutics, Inc. Dr. Mansuri is also Executive VP-Strategy & Business Development at Sanofi.
In his past career Dr. Mansuri occupied the position of General Partner at Flagship Pioneering, SVP-Research & Development Strategy at Gilead Sciences, Inc. and Chairman & Chief Executive Officer at Gilead Connecticut, Inc. (a subsidiary of Gilead Sciences, Inc.), Director-Central Chemistry at Bristol-Myers Squibb Co., Senior Advisor at JSB-Partners LP, Chief Operating Officer & Executive Vice President of GPC Biotech, Inc., President & Chief Executive Officer at BIKAM Pharmaceuticals, Inc. and Research Scientist at Shell Research Ltd.
Dr. Mansuri received a doctorate and an undergraduate degree from University College London, a doctorate from the University of California, Los Angeles and a doctorate from Columbia University. |
| Carole Piwnica |
Ms. Carole Piwnica is Member-Supervisory Board at Rothschild & Co. SCA, Chairman at i2O Water Ltd., Independent Director at Sanofi, Independent Director at Eutelsat Communications SA, Independent Director at Amyris, Inc., a Director at Select Music & Video Distribution Ltd., a Managing Director at Naxos UK Ltd., a Managing Director at NAXOS Capital Managers SARL, a Member at New York State Bar Association and a Member at Paris Bar Association. She is on the Board of Directors at Rothschild & Co. SCA, Sanofi, Elevance Renewable Sciences, Inc., Eutelsat Communications SA, Amyris, Inc., Big Red, Inc., Select Music & Video Distribution Ltd. and RecyCoal Ltd.
Ms. Piwnica was previously employed as Independent Director by Louis Delhaize SA, Independent Non-Executive Director by Aviva Plc, Non-Executive Director by SPADEL SA, a Director & Vice Chairman-Governmental Affairs by Tate & Lyle Plc, and Chairman by Amylum. She also served on the board at BioAmber, Inc., Confederation of the Food & Drink Industries of Eu, Alfred C. Toepfer International GmbH, Charal SAS, Cacao Barry, and TargeGen, Inc.
Ms. Piwnica received her graduate degree from Université Libre de Bruxelles and a graduate degree from New York University. |
| Christian Mulliez |
Currently, Christian Mulliez is Chief Financial Officer & EVP-Administration at L'Oréal SA and Chairman for Banque de Réalisations de Gestion et de Financement (a subsidiary of L'Oréal SA). He is also on the board of Sanofi and Dg 17 Invest.
In his past career he held the position of Vice President-Finance at Sanofi-Synthélabo SA and Vice President-Finance of Synthélabo SA.
Christian Mulliez received an undergraduate degree from ESSEC Business School. |
| Melanie Georgina Lee |
Founder of Think10 and NightstaRx Ltd., Melanie Georgina Lee is on the board of Sanofi and UK DRI Ltd. and Chief Executive Officer of Lifearc.
Dr. Lee previously held the position of Chairman of Cancer Research Technology Ltd., Chief Executive Officer for NightstaRx Ltd., Executive Vice President-Research & Development at UCB Pharma, Inc., Director-Research & Development at Celltech Group Ltd., Chief Scientific Officer at BTG Plc, President-New Medicines at UCB Celltech, Principal at GlaxoSmithKline Pharmaceuticals SA (Belgium), Research Unit Head-Receptor Systems at GlaxoWellcome and Director at Think10.
She received an undergraduate degree from York University. |
| Patrick Kron |
Olivier Brandicourt is a French businessperson who has been at the helm of 6 different companies. He occupies the position of Chief Executive Officer & Director at Sanofi and Chairman for Sanofi Biotechnology SAS (a subsidiary of Sanofi). He is also on the board of National Committee on United States-China Relations, Inc. and Chairman of Pharmaceutical Research & Manufacturers of America, Vice President & Member at European Federation of Pharmaceutical Industries & Assns and Council Member at International Federation of Pharmaceutical Manufacturers.
He previously held the position of President & General Manager-Emerging Markets at Pfizer Inc. Managing Director at Pfizer Ltd. Managing Director at Pfizer Manufacturing Ireland Unlimited Co. Vice President at Warner-Lambert Co. and Vice President & General Manager at Parke, Davis & Co. LLC (which are all subsidiaries of Pfizer Inc.) and Executive Council Member at Bayer AG and Chairman-Management Board at Bayer HealthCare AG (a subsidiary of Bayer AG).
He received a doctorate and a graduate degree from Université Paris XII and an undergraduate degree from the University of Paris V. |
| Elias A. Zerhouni |
Dr. Elias A. Zerhouni, MD, is a President-Global Research & Development at Sanofi, a Member at Académie Nationale de Médecine, an Independent Director at Danaher Corp., a Member at National Academy of Engineering, a Member at Institute of Medicine and a Professor at The Johns Hopkins University. He is on the Board of Directors at Danaher Corp., Research!America, Warp Drive Bio LLC and King Abdullah University of Science & Technology. Dr. Zerhouni was previously employed as a Trustee-Emeritus by The Mayo Clinic, a Chairman & President by The Zerhouni Group LLC, a Chairman-Innovation by College de France, a Trustee by Lasker Foundation, and a Chairman-Russell H. Morgan Department by The Johns Hopkins Health System Corp. He also served on the board at Actelion Ltd., National Institutes of Health and Mayo Medical Ventures. He received his doctorate degree from The University of Algiers. |
| Laurent Attal |
Currently, Laurent Attal holds the position of Vice President & GM-Research & Innovation at L'Oréal SA. Dr. Attal is also on the board of Sanofi and L'Oréal Corporate Foundation.
In his past career Dr. Attal was Chief Executive Officer of Vichy, President & Chief Executive Officer of L'Oréal USA, Inc. and Manager at Galderma SA.
Dr. Attal received an MBA from INSEAD. |
| Robert Castaigne |
Dr. Robert Castaigne is an Independent Director at NOVATEK JSC, an Independent Non-Executive Director at Société Générale SA, an Independent Director at VINCI SA and an Independent Director at Sanofi. He is on the Board of Directors at NOVATEK JSC, Société Générale SA, VINCI SA, Sanofi, Omnium Insurance & Reinsurance Co. Ltd., Total Gestion Filiales and Total Upstream UK Ltd. Dr. Castaigne was previously employed as an Independent Non-Executive Director by Cie Nationale à Portefeuille SA /OLD/, an Independent Director by Sanofi, a Chairman & Chief Executive Officer by Total Chimie SA, and a Chief Financial Officer by Total SA. He also served on the board at Total Gabon, Arkema SA, Elf Aquitaine SA, Hutchinson SA, NPM-CNP, Petrofina SA and Total Nucleaire. He received his undergraduate degree from École centrale de Lille, an undergraduate degree from IFP School and a doctorate degree from Université Paris 1. |
| Claudie Haigneré |
Claudie Haigneré is Member of Academie de l'air et de l'espace, Member of Académie des Sciences et Technologies, Member of Académie Des Sciences D'Outre-Mer and Member of Academie des Sports and on the board of 6 other companies.
In the past she was Chairman at Universcience.fr, Chairman for La Géode, Counselor at European Space Agency, Member of International Academy of Astronautics and Member of Académie des Technologies. |
| Karen Linehan |
Currently, Karen Linehan holds the position of Executive VP-Legal Affairs & General Counsel at Sanofi.
Ms. Linehan received a graduate degree and an undergraduate degree from Georgetown University. |
| Suet-Fern Lee |
Suet-Fern Lee founded Stamford Law Corp. Currently, Ms. Lee is Partner at Morgan Lewis Stamford LLC. She is also Member of The Bar Council, Chairman-Legal Education & Studies Committee at Singapore Academy of Law, Member of Singapore Bar and Member of International Bar Association and on the board of 10 other companies.
Ms. Lee previously held the position of Senior Partner at Stamford Law Corp., President for Inter-Pacific Bar Association, Member of National Heritage Board, Chairman at Asian Civilisations Museum and Member of The Honourable Society of Gray's Inn.
She received a graduate degree from the University of Cambridge. |
| Emmanuel Andre Marie Babeau |
Currently, Emmanuel Andre Marie Babeau is Deputy Chief Executive Officer-Finance & Legal at Schneider Electric SE. He is also Managing Partner at Sci Getij and on the board of 15 other companies.
In his past career he occupied the position of Deputy Chief Executive Officer of Pernod Ricard SA, Chairman & Member-Management Board at Schneider Electric Services International, Chief Financial Officer of Schneider Electric Ltd. and Member-Management Board at Schneider SA.
He received an undergraduate degree from ESCP Europe Campus Paris. |
| Karen Linehan |
Currently, Karen Linehan holds the position of Executive VP-Legal Affairs & General Counsel at Sanofi.
Ms. Linehan received a graduate degree and an undergraduate degree from Georgetown University. |
| Philippe Luscan |
Philippe Luscan is Executive Vice President-Global Industrial Affairs at Sanofi.
Mr. Luscan previously held the position of Production Manager at Danone SA.
He received an undergraduate degree from Ecole Polytechnique and an undergraduate degree from École Nationale Supérieure des Mines de Paris. |
| Olivier Antoine M. Charmeil |
Olivier Antoine M. Charmeil is EVP-General Medicines & Emerging Markets at Sanofi.
In the past Mr. Charmeil occupied the position of Chairman-Management Board at Zentiva Group as, Chairman & Chief Executive Officer of Sanofi-Synthélabo SA and Head-Business Development at Sanofi Pharma.
Mr. Charmeil received an undergraduate degree from Sciences Po and an undergraduate degree from École des Hautes Études Commerciales de Paris. |
| Fabienne Lecorvaisier |
Currently, Fabienne Lecorvaisier occupies the position of Chief Financial Officer & Executive Vice President of Air Liquide SA and Chairman & Chief Executive Officer of Air Liquide Finance SA and Executive Vice President at Air Liquide International Corp. (both are subsidiaries of Air Liquide SA). She is also Executive Vice President at Air Liquide International Corp. and on the board of 6 other companies.
Ms. Lecorvaisier previously was Vice President-Operations & Finance at Air Liquide Italia SpA, Chief Financial Officer at Essilor Group Canada, Inc., Director-Finance & Information Systems at Essilor of America, Inc., Assistant General Manager at Taittinger SAS and Assistant General Manager at Banque du Louvre.
Ms. Lecorvaisier received an undergraduate degree from Ecole Nationale des Ponts et Chaussées. |
| Thomas C. Südhof |
Founder of Reata Pharmaceuticals, Inc., Neucyte, Inc. and Circuit Therapeutics, Inc., Thomas C. Südhof is an entrepreneur is on the board of Sanofi and Abide Therapeutics, Inc. and Professor at Stanford University School of Medicine.
In the past he was Assistant Professor at The University of Texas Southwestern Medical Center.
He received a doctorate from RWTH Aachen University and an undergraduate degree from the University of Gottingen. |
| Jean-Baptiste Chasseloup de Chatillon |
Jean-Baptiste Chasseloup de Chatillon is a French businessperson who has been at the helm of 5 different companies. Currently, he occupies the position of Chief Financial Officer & Executive Vice President for Sanofi, Chairman for Mister-Auto SAS and Vice Chairman & Chief Executive Officer of PSA International SA. He is also Chief Financial & Information Officer at Fondation PSA Peugeot Citroën, Member of City on the Move Institute and Associate Manager at Peugeot Media Production and on the board of 12 other companies.
In his past career Mr. Chasseloup de Chatillon held the position of Chairman for Asm Auto Sud Marche SAS and CFO & Executive VP-Strategic Development at Peugeot SA Director at Banque PSA Finance SA, Chairman-Supervisory Board of Peugeot Finance International NV and Managing Director at Citroën BELUX SA (which are all subsidiaries of Peugeot SA).
He received an undergraduate degree from Université Paris Dauphine and an undergraduate degree from the University of Lancaster. |
| Dominique Carouge |
Dominique Carouge holds the position of Executive VP & Head-Business Transformation at Sanofi.
In his past career Mr. Carouge was Chief Financial Officer for Hoechst Marion Roussel Australia Pty Ltd.
Mr. Carouge received an undergraduate degree from Reims Management School. |
| Caroline Luscombe |
Presently, Caroline Luscombe is Executive Vice President-Human Resources at Sanofi.
In the past Ms. Luscombe was Head-Organization & Human Resources at LafargeHolcim Ltd., Executive Vice President-Human Resources of Amersham Plc and Head-Human Resources at Syngenta AG.
She received an undergraduate degree from University College London. |
| Muzammil M. Mansuri |
Currently, Muzammil M. Mansuri is Executive Chairman at Adaptive Therapeutics, Inc. Dr. Mansuri is also Executive VP-Strategy & Business Development at Sanofi.
In his past career Dr. Mansuri occupied the position of General Partner at Flagship Pioneering, SVP-Research & Development Strategy at Gilead Sciences, Inc. and Chairman & Chief Executive Officer at Gilead Connecticut, Inc. (a subsidiary of Gilead Sciences, Inc.), Director-Central Chemistry at Bristol-Myers Squibb Co., Senior Advisor at JSB-Partners LP, Chief Operating Officer & Executive Vice President of GPC Biotech, Inc., President & Chief Executive Officer at BIKAM Pharmaceuticals, Inc. and Research Scientist at Shell Research Ltd.
Dr. Mansuri received a doctorate and an undergraduate degree from University College London, a doctorate from the University of California, Los Angeles and a doctorate from Columbia University. |
| Claire Massiot-Jouault |
Ms. Claire Massiot-Jouault is Head-Operational Excellence & Lean Manufacturing at Sanofi and General Manager at La Residence de la Ferme De Croisil. She is on the Board of Directors at Guerbet SA. She received her graduate degree from Université Pierre et Marie Curie and a doctorate degree from the University of Paris V. |
| Paul Hudson |
Paul Hudson is a businessperson who has been the head of 5 different companies. Presently, he is Chief Executive Officer of Sanofi and Chairman for Novartis Pharma KK.
In his past career Mr. Hudson occupied the position of Member-Executive Committee at Novartis AG and Chief Executive Officer of Novartis Pharmaceuticals Corp. (a subsidiary of Novartis AG) and President-AstraZeneca US & EVP-North America at AstraZeneca Plc President & Director at AstraZeneca KK and President of AstraZéneca Farmacéutica Spain SA (both are subsidiaries of AstraZeneca Plc).
Mr. Hudson received an undergraduate degree from Manchester Metropolitan University of. |
| Ameet Nathwani |
Ameet Nathwani occupies the position of Chief Medical & Digital Officer at Sanofi.
He previously occupied the position of Global Head-Medical Affairs at Novartis Pharma AG and Head-Critical Care at Novartis Pharma AG. |
| Muzammil M. Mansuri |
Currently, Muzammil M. Mansuri is Executive Chairman at Adaptive Therapeutics, Inc. Dr. Mansuri is also Executive VP-Strategy & Business Development at Sanofi.
In his past career Dr. Mansuri occupied the position of General Partner at Flagship Pioneering, SVP-Research & Development Strategy at Gilead Sciences, Inc. and Chairman & Chief Executive Officer at Gilead Connecticut, Inc. (a subsidiary of Gilead Sciences, Inc.), Director-Central Chemistry at Bristol-Myers Squibb Co., Senior Advisor at JSB-Partners LP, Chief Operating Officer & Executive Vice President of GPC Biotech, Inc., President & Chief Executive Officer at BIKAM Pharmaceuticals, Inc. and Research Scientist at Shell Research Ltd.
Dr. Mansuri received a doctorate and an undergraduate degree from University College London, a doctorate from the University of California, Los Angeles and a doctorate from Columbia University. |
| Diane D. Souza |
Diane D. Souza is on the board of Sanofi, Farm Credit East, ACA and DBP Services of New York IPA, Inc. In the past he held the position of Chief Executive Officer-Specialty Benefits at UnitedHealth Group, Inc. Chief Executive Officer of UnitedHealthcare Specialty Benefits LLC and COO-OptumHealth Specialty Benefits at OptumHealth, Inc. (both are subsidiaries of UnitedHealth Group, Inc.) and CFO-Guaranteed Products Business at Aetna, Inc.
He received an undergraduate degree from the University of Massachusetts. |
| Bill Sibold |
Bill Sibold is on the board of Biotechnology Innovation Organization and Executive Vice President-Sanofi Genzyme at Sanofi. |
| Stefan Oelrich |
Stefan Oelrich is Executive VP-Diabetes & Cardiovascular at Sanofi and Head-Pharmaceuticals Division at Bayer AG. |
| Marion Palme |
Marion Palme is on the board of Sanofi and Member of Industriegewerkschaft Bergbau Chemie Energie.
She previously held the position of Member of European Works Council.
Ms. Palme received an undergraduate degree from Provadis School of International Management & Technology. |
| Christian Senectaire |
Christian Senectaire is on the board of Sanofi. |
| Klaus Henning Jensen |
Klaus Henning Jensen is Therapeutic Area Head & Diabetes Development at Sanofi. |
| Nestle Frank |
Nestle Frank is Global Head-Immunology Therapeutic Research Area at Sanofi. |
| Joanne Lager |
Joanne Lager is Vice President & Head-Development at Sanofi. |
| Christophe Babule |
Presently, Christophe Babule is Chief Financial Officer & Executive Vice President at L'Oréal SA. Mr. Babule is also on the board of Sanofi.
Mr. Babule received an undergraduate degree from École des Hautes Études Commerciales de Paris. |
| Alan Main |
Alan Main is Executive Vice President-Consumer Health Care at Sanofi.
In the past Mr. Main held the position of Marketing Manager at Roche Enterprises Ltd. and Chairman-Marketing Council at Bayer HealthCare AG.
He received an undergraduate degree from the University of Greenwich. |
| Claire Terrazas |
Presently, Claire Terrazas occupies the position of Vice President-Corporate Legal Affairs at Sanofi. |
